Reliv International, Inc. (NASDAQ:RELV) recently reported net sales of $9.1 million for the third quarter of 2019.
The net sales compared with net sales of $8.3 million in the third quarter of 2018. Net sales in the U.S. increased by $344,000, which represented a 5.3 percent increase in net sales when compared to the prior-year quarter. Net sales in the U.S. were favorably impacted by the launch of the RLV line of hemp-extract products near the end of the second quarter of 2019.
Net sales in Reliv’s foreign markets increased by $468,000, or 25.5 percent, in the third quarter of 2019 compared with the prior-year quarter. Net sales in Asia and Mexico increased by 93.3 percent and 21.9 percent, respectively, offset by decreases in all other regions.
Net sales for the first nine months of 2019 were $26.9 million, which represents a 0.4 percent increase from the same period in 2018. Net sales in the U.S. decreased by 3.2 percent and net sales in Reliv’s foreign markets increased by 11.8 percent in the first nine months of 2019 compared with the same period last year.
As of September 30, 2019, Reliv had 34,000 active distributors and preferred customers – an increase of 11.3 percent from September 30, 2018 – of which 3,140 are Master Affiliate level and above.
“We are excited about the addition of the RLV line into the Reliv product family,” said Ryan A. Montgomery, chief executive officer. “Not only is it providing a spark in U.S. sales, it has created excitement in the entire Reliv business leading to a growth in new distributors and customers for all of the Reliv products. Additional products in the RLV line are in development for introduction within the next year.”
To read the full Reliv Q3 2019 financial report, click here.
